Status:

RECRUITING

Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis

Lead Sponsor:

University of St. Augustine for Health Sciences

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Rationale: The Balance-Based Torso-Weighting (BBTW) is a patented evaluation system that uses strategic placement of small or lightweight weights on the trunk to improve balance and stability. BBTW ha...

Detailed Description

Research Questions: Question #1 - Is there a difference in EMG within postural muscles (tibialis anterior and gastrocsoleus) and between healthy and MS when not wearing weighted vest with eyes open? ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Individuals with Multiple Sclerosis group:
  • self-reported diagnosis of multiple sclerosis (MS)
  • age 18 to 75 years old
  • able to communicate in English
  • able to provide informed consent
  • able to tolerate up to three hours of testing with rest breaks
  • able to walk 20 meters with or without assistive device and without resting (equivalent to Expanded Disability Status Scale of 6.5 or less).
  • Inclusion criteria for the Healthy Control group:
  • able to communicate in English
  • able to provide informed consent
  • physical criteria that matched each participant with MS which included age (within 7 years), height (within 12.7 cm \[5 in\]), mass (within 9.1 kg \[20 lb\]) and sex.
  • Exclusion Criteria for Individuals with Multiple Sclerosis group:
  • exacerbation of MS within the past two months
  • had a diagnosis of a concurrent neurological disorder (head injury, stroke, Parkinson's disease, etc.)
  • reported pain that could be exacerbated by external perturbations during standing.
  • Exclusion Criteria for Healthy control group:
  • Known diagnoses
  • current pain that could affect balance.

Exclusion

    Key Trial Info

    Start Date :

    March 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2026

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06981013

    Start Date

    March 1 2025

    End Date

    December 1 2026

    Last Update

    May 20 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of St. Augustine for Health Sciences

    Saint Augustine, Florida, United States, 32086